Synergistic Neutralization of a Chimeric SIV/HIV Type 1 Virus with Combinations of Human Anti-HIV Type 1 Envelope Monoclonal Antibodies or Hyperimmune Globulins-Reference-Cited by-同舟云学术

Synergistic Neutralization of a Chimeric SIV/HIV Type 1 Virus with Combinations of Human Anti-HIV Type 1 Envelope Monoclonal Antibodies or Hyperimmune Globulins

Published:1997-05-20 Issue:8 Volume:13 Page:647-656
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

LI AN,BABA TIMOTHY W.,SODROSKI JOSEPH,ZOLLA-PAZNER SUSAN,GORNY MIROSLAW K.,ROBINSON JAMES,POSNER MARSHALL R.,KATINGER HERMANN,BARBAS CARLOS F.,BURTON DENNIS R.,CHOU TING-CHAO,RUPRECHT RUTH M.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.1997.13.647

Reference35 articles.

1. Summary of the Working Group on Perinatal Intervention

2. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

3. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.

4. Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies

5. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 Not Inform the Rational Design of an HIV-1 Vaccine?;HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design;2019

2. New-Generation High-Potency and Designer Antibodies: Role in HIV-1 Treatment;Annual Review of Medicine;2018-01-29

3. Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual;PLOS ONE;2015-05-11

4. Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?;AIMS Public Health;2015

5. Frequently asked questions in drug combinations and the mass-action law-based answers;Synergy;2014-09